STAGE IIC FALLOPIAN TUBE CANCER AJCC V6 AND V7
Clinical trials for STAGE IIC FALLOPIAN TUBE CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIC FALLOPIAN TUBE CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IIC FALLOPIAN TUBE CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ovarian cancer study tests which chemo combo works best
Disease control OngoingThis study compares two chemotherapy regimens (carboplatin+paclitaxel vs oxaliplatin+capecitabine), with or without the drug bevacizumab, as first treatment for mucinous ovarian or fallopian tube cancer. About 50 participants with newly diagnosed or recurrent disease are enrolled…
Matched conditions: STAGE IIC FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:57 UTC
-
Weekly chemo may improve outcomes for advanced ovarian cancer patients
Disease control OngoingThis study tested two different ways of giving the chemotherapy drug paclitaxel (either once every three weeks or once a week) along with carboplatin, with or without the targeted drug bevacizumab, in 692 people with advanced ovarian, peritoneal, or fallopian tube cancer. The goa…
Matched conditions: STAGE IIC FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC